Aspirin versus clopidogrel monotherapy for the treatment of patients with stable coronary artery disease: a systematic review and meta-analysis
J Yuan, GM Xu, J Ding - Advances in therapy, 2019 - Springer
Introduction Although aspirin (ASA) is the mainstay of treatment for the prevention of
recurrent ischemic stroke, the Clopidogrel versus Aspirin in Patients at Risk of Ischemic …
recurrent ischemic stroke, the Clopidogrel versus Aspirin in Patients at Risk of Ischemic …
The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of …
Background Other than aspirin, there are few oral antithrombotic treatments with proven
efficacy in patients with acute coronary syndrome. In this report, we present the rationale …
efficacy in patients with acute coronary syndrome. In this report, we present the rationale …
Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable …
Background—We studied the benefits and risks of adding clopidogrel to different doses of
aspirin in the treatment of patients with acute coronary syndrome (ACS). Methods and …
aspirin in the treatment of patients with acute coronary syndrome (ACS). Methods and …
Clopidogrel use as single antiplatelet therapy in outpatients with stable coronary artery disease: prevalence, correlates and association with prognosis (from the …
G Lemesle, G Schurtz, T Meurice, O Tricot, N Lemaire… - Cardiology, 2016 - karger.com
Background: Clopidogrel use as single antiplatelet therapy (SAPT) has never been
evaluated in stable coronary artery disease (CAD) outpatients either as compared to …
evaluated in stable coronary artery disease (CAD) outpatients either as compared to …
Clopidogrel monotherapy versus aspirin monotherapy in patients with established cardiovascular disease: systematic review and meta-analysis
Background There is no clear consensus on whether aspirin offers better outcomes in terms
of secondary cardiovascular disease prevention compared with clopidogrel. Objective The …
of secondary cardiovascular disease prevention compared with clopidogrel. Objective The …
Aspirin and clopidogrel: a sweeping combination in cardiology
AS Manolis, S Tzeis, G Andrikopoulos… - Current Medicinal …, 2005 - ingentaconnect.com
Platelets play a pivotal role in the pathogenesis of atherothrombosis, believed to be
integrally involved in both the development and progression of atherosclerotic heart …
integrally involved in both the development and progression of atherosclerotic heart …
Should We Use Aspirin or P2Y12 Inhibitor Monotherapy in Stable Ischemic Heart Disease?
Abstract Purpose of Review To summarize the recent evidence and guideline
recommendations on aspirin or P2Y12 inhibitor monotherapy in patients with stable …
recommendations on aspirin or P2Y12 inhibitor monotherapy in patients with stable …
Long-term combination therapy with aspirin and clopidogrel
CR Kumana, G Cheung, IJ Lauder… - Journal of …, 2004 - journals.sagepub.com
The possible additive antiplatelet effects of aspirin and clopidogrel have been explored in
the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) and Management …
the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) and Management …
Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events
Background and Purpose—The goal of this study was to examine the influence of
preexisting symptomatic atherosclerotic disease on subsequent ischemic event rates and …
preexisting symptomatic atherosclerotic disease on subsequent ischemic event rates and …
Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups
Background—The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial
demonstrated that clopidogrel, given early and continued long term, was superior to placebo …
demonstrated that clopidogrel, given early and continued long term, was superior to placebo …